MD CARDIO
The computed 12-month bankruptcy probability of MD CARDIO is 0.2% (very low). The 2025 annual accounts show equity of €9k and a net result of €87k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 17% of 2209 sector peers (fiscal year 2025). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €9k |
| Net result | €87k |
| Better than sector | 17% |
| Active | 4 yrs |
Strong profile, led by profitability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 4.5% | 58.2% | |
| Net result | €87k | €60k | |
| Equity | €9k | €74k | |
| Gross operating margin | €118k | €96k | |
| Total assets | €190k | €187k |
| Fiscal year | 2025 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | €118k |
| Net profit | €87k |
| Cash flow | €95k |
| Staff costs | - |
| Income taxes | €24k |
| Dividends | €492k |
| Total assets | €190k |
| Equity | €9k |
| Debt | €181k |
| of which ≤ 1y | €181k |
| of which > 1y | - |
| Working capital | €-6k |
| Employees (FTE) | - |
| 2025 | |
|---|---|
| Current ratio | 0.97 |
| Quick ratio | 0.97 |
| Working capital ratio | -3.1% |
| Solvency | 4.5% |
| Debt / equity | 21.08 |
| Long-term debt ratio | - |
| Interest coverage | 972.13 |
| Gross margin | - |
| Net margin | - |
| ROA | 45.8% |
| ROE | 1012.3% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €190k |
| Fixed assets | 21/28 | €14k |
| Formation expenses | 20 | €0 |
| Tangible fixed assets | 22/27 | €13k |
| Financial fixed assets | 28 | €1k |
| Current assets | 29/58 | €175k |
| Amounts receivable within one year | 40/41 | €49k |
| Investments | 50/53 | €34k |
| Cash & bank | 54/58 | €91k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €190k |
| Equity | 10/15 | €9k |
| Contributions / capital | 10/11 | €2k |
| Accumulated profits (losses) | 14 | €7k |
| Amounts payable | 17/49 | €181k |
| Amounts payable within one year | 42/48 | €181k |
| Trade debts payable within one year | 44 | €48 |
| Income statement | ||
| Gross operating margin | 9900 | €118k |
| Operating result | 9901 | €110k |
| Financial income | 75 | €816 |
| Financial charges | 65 | €122 |
| Result before taxes | 9903 | €111k |
| Income taxes | 67/77 | €24k |
| Net result for the period | 9904 | €87k |
| Result to be appropriated | 9905 | €87k |
| NACE primary | Activiteiten van medisch specialisten(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 11-11-2021 |
| Status | Active |
| Postal code | 4537 |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
09-12-2022 Registered office moved to Verlaine
- Rue Buisson à la fleur, 4 à 4537 Verlaine.
Technical details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Rue Buisson \u00E0 la fleur, 4 \u00E0 4537 Verlaine.",
"city": "Verlaine",
"region": "waals_gewest",
"street": "Rue Buisson \u00E0 la fleur",
"country": "BE",
"postcode": "4537",
"box_number": null,
"street_number": "4",
"locality_suffix": null
},
"old_address": null,
"effective_date": null,
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": null,
"old_address_source": "inferred",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": null,
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2022-12-09",
"filing_date": "2022-11-30",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"date": "2022-11-03",
"unanimous": null
},
"subject_company": {
"kbo": "0777.291.088",
"name_full": "IBUNAL DE L\u0027ENTREPRISE DE LIEG",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "SH La Compt\u0027active",
"person_name": null,
"org_rep_person_name": "Christel THONET",
"person_role_at_subject": null
},
"co_filed_documents": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | MD CARDIO |